Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
“Mark Cuban isn’t solely on a mission to lower the price of popular prescription medications you might purchase from your favorite pharmacy. The billionaire entrepreneur and cofounder of the Mark Cuban Cost Plus Drug Co. wants to make so-called specialty drugs more accessible too.”
Needle Programs Need Second Look
“Whether it be willful ignorance or a genuine misunderstanding of the broad range of strategies necessary to tackle a dual public health crisis in Appalachia, elected officials and policymakers are handicapping efforts against one of the major dangers spawned by our region’s substance abuse epidemic.”
OHSU study shows how peers with lived experience can help in fight against hepatitis C
“According to the Centers for Disease Control and Prevention, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or death if left untreated. Injection drug use is the leading risk factor for hepatitis C, which is also more prevalent in rural counties where diagnosis and treatment can be hard to come by, especially for people experiencing homelessness.”
Woman infected with Hepatitis C — allegedly by Portland-area anesthesiologist during surgery — sues for $4M
“A Portland-area woman who claims the anesthesiologist in her 2021 hand surgery infected her with the potentially life-threatening Hepatitis C virus filed a $4 million lawsuit against Providence Health & Services and the Oregon Anesthesiology Group on Wednesday.”
Lipophilic Statins May Protect Against HCC In Select Liver Disease Patients
“Lipophilic statins are associated with reduced risk of developing hepatocellular carcinoma (HCC) among patients with hepatic fibrosis and cirrhosis, according to investigators. These findings also pave the way for new research into targeted therapies, personalized prevention strategies, and broader applications in high-risk populations, Erik Almazan, MD, and Raymond T. Chung, MD, of Harvard Medical School, Boston, Massachusetts, reported.”